Dangerous Drug News

Side Effect Information About Dangerous Drugs and Medical Devices

Altrumedia
  • Home
  • About
  • Dangerous Drug News
  • Drugs
    • Fluoroquinolone Antibiotics
    • Pradaxa
    • Proton Pump Inhibitors
    • Risperdal
    • Talcum Powder
    • Taxotere
    • Xarelto
    • Zofran
  • Medical Devices
    • Essure
    • IVC Filters
    • Power Morcellators
    • Transvaginal Mesh
  • Free Case Evaluation

Type 2 Diabetes Drugs Pose Numerous Health Risks

June 6, 2019 By Lynn Fugaro Leave a Comment

Diabetic Man Testing Blood Levels

The hits just keep coming for Johnson & Johnson, and now its Type 2 diabetes drug, Invokana, is in the spotlight, again.

Invokana, Invokamet, Farxiga, and Xigduo are in a newer class of diabetes drugs called “sodium-glucose co-transporter 2 (SGLT2) inhibitors”. These drugs are designed to lower blood sugar in people with Type 2 Diabetes by preventing glucose from being reabsorbed into the blood by the kidneys. With these drugs, glucose is instead excreted through the kidneys in urine. The generic drug name for Invokana and Invokamet is canagliflozin, and the generic drug name for Farxiga and Xigduo is dapagliflozin.

Over the past several months, these drugs have been linked to a condition known as Fournier’s gangrene, which is a necrotizing fasciitis of the peritoneum, also known as gangrene of the genitals.  As SGLT2 inhibitors prompt the kidneys to remove sugar from the body through urine, the sugary urine leaves the body but creates the perfect environment for bacteria to grow.

With the favorable environment for bacteria grow, Fournier’s gangrene can occur if there’s a nick in the skin from shaving. A painful infection may affect the perineum, scrotum, or penis and may cause scrotum pain and redness. There may be a foul odor in the area, and the condition can lead to dehydration and anemia.

Invokana (and others) May Lead to Other Serious Health Risks

According to the Food and Drug Administration (FDA), the SGLT2 drugs (Invokana, Invokamet, Farxiga, and Xigduo) have been linked to other serious adverse health conditions; Invokana is already the subject of litigation that alleges it causes severe kidney damage including diabetic ketoacidosis. Now, there’s new evidence that these drugs may lead to a risk of foot and leg amputations in addition to these already-known risks:

  • Ketoacidosis
  • Heart attack
  • Bone fracture
  • Kidney failure

Acute Kidney Failure and Type 2 Diabetes Drugs

With acute kidney failure, the kidneys suddenly stop filtering waste products from your blood, which may cause a buildup of toxins. Acute kidney failure often requires hospitalization and can be fatal if not treated quickly and properly. While some people fully recover from acute kidney failure with proper treatment, many people are left with permanent, serious injuries.

Symptoms of acute kidney damage include:

  • Decreased urine output
  • Fluid retention
  • Swollen legs and feet
  • Fatigue
  • Drowsiness
  • Confusion
  • Nausea
  • Shortness of breath
  • Chest pain
  • Pressure in the chest
  • Seizures in the most serious cases
  • Coma in the most serious cases

New Concern, FDA Warns

In May 2019, the FDA required Johnson & Johnson to add new warnings to the Ivokana label about the risk of foot and leg amputations. The results from two clinical trials showed leg and foot amputations occurred about twice as often in patients with Type 2 diabetes treated with Invokana as those given a placebo, the FDA announced on its website recently.
It’s estimated that over 29 million suffer with Type 2 diabetes in the United States, alone. If you have taken one of these dangerous drugs, please find a product liability attorney in your area who handles difficult defective product cases. Also, if you’re taking one of these drugs, do not stop taking the drug without first speaking to your physician. Not all drugs can be abruptly stopped safely.

Share this:

  • Facebook
  • LinkedIn
  • Twitter

Filed Under: Dangerous Drug, Invokana

Avatar

About Lynn Fugaro

Lynn has been writing web content since 2007 after a lengthy career as a middle school English teacher and administrator. Writing web content seemed a natural progression following a career teaching adolescents about the beauty and the power of the written word, and she quickly got hooked on the challenge of writing SEO- and reader-friendly content that could be found on Page 1 of Google and other search engines.

Having written content for physicians and attorneys for the first few years of her writing career, Lynn has most recently produced original, informative, entertaining, and relevant content for the entertainment industry, the automotive industry, senior communities, pet rescues and numerous other businesses hoping to increase website traffic and page views for all clients looking for informative, vibrant content.

Leave a Reply Cancel reply

You must be logged in to post a comment.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

RSS FDA Med Watch

  • FDA and CDC Recommend Pause in Use of Ixchiq (Chikungunya Vaccine, Live) in Individuals 60 Years of Age and Older While Postmarketing Safety Reports are Investigated: FDA Safety Communication
  • FDA Advises Consumers, Tattoo Artists, and Retailers to Avoid Using or Selling Certain Sacred Tattoo Ink Products Contaminated with Microorganisms
  • EnShiShiXiangNiShangMaoYouXianGongSi Issues Voluntary Nationwide Recall of ENDURANCE BOOST WITH HORNY GOAT WEED Capsules Due To Presence of Undeclared Propoxyphenylsildenafil and Sildenafil
  • Heart Pump Accessory Removal: Abbott Removes HeartMate Mobile Power Unit due to Instances of Sudden Power Loss
  • Risk of False Positive Results with Certain Capillary Blood Collection Tubes Used with Magellan Diagnostics LeadCare Testing Systems – FDA Safety Communication
  • Early Alert: Intravascular PICC Catheter Issue from BD
  • Early Alert: Diagnostic Intravascular Catheter Issue from Conavi

Recent Headlines

Diabetic Man Testing Blood Levels

Type 2 Diabetes Drugs Pose Numerous Health Risks

The hits just keep coming for Johnson & Johnson, and now its … [Read More...]

PPIs Side Effects

PPI Heartburn and Ulcer Medications May Cause Stomach Cancer

Proton pump inhibitors (PPIs) are used to treat heartburn, … [Read More...]

Johnson & Johnson Loses Second Major Talcum Powder Case

In its second trial loss in less than 3 months, Johnson & … [Read More...]

Find an Attorney

RSS US Recall News

  • Belviq Withdrawn Due to Cancer Risk
  • Common Heartburn Medication may lead to bladder, stomach, and other cancers. Zantac Lawsuits begin.
  • J&J Settles Talc Mesothelioma Settlement

RSS Lawsuits and Settlements

  • Possible Lawsuit: Suboxone Tooth Decay Legal News and Lawsuit Information
  • Possible Lawsuit: Ozempic and Mounjaro Weight Loss Lawsuit News and Legal Information
  • Possible Lawsuit: CPAP Lung Cancer Lawsuit News and Legal Information

RSS Mass Tort News

  • An error has occurred, which probably means the feed is down. Try again later.

RSS Health Industry

  • IPO Pipeline Restarts As Tariff-Related Volatility Eases
  • J&J Unit Hit With $147M Verdict In Catheter Antitrust Suit
  • Fla. Gov. Says He Will Veto Bill To Expand Death Damages

ABOUT US

DRUG INFO

DEVICES

CASE REVIEW

NEWS

Copyright © 2025 DangerousDrugNews.com · Site Map - Website Development by Altrumedia · Log in